| Cvs Pharmacy #16645 | |
| 1816 Gunbarrel Rd, Chattanooga, Tennessee 37421 | |
| (423) 954-9063 |
| Name | Cvs Pharmacy #16645 |
|---|---|
| Organization Name | Tennessee Cvs Pharmacy Llc |
| Location | 1816 Gunbarrel Rd, Chattanooga, Tennessee 37421 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (423) 954-9063 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Genetic testing for a certain mutation in pediatric patients is valuable in determining a cause for unexplained hearing loss, according to a study in the November 2012 issue of Otolaryngology-Head and Neck Surgery.
Cardiac patients who also have diabetes will be able to do their rehabilitation exercises more safely, thanks to the world's first guidance on the subject, which has been published by international experts including a Swansea University academic.
For snakes, spiders, and other venomous creatures, the "business end," or active part, of a toxin is the area on the surface of a protein that is most likely to undergo rapid evolution in response to environmental constraints, say researchers from Ben Gurion University in Israel.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 3 days ago
| NPI Number | 1689696338 |
| Organization Name | TENNESSEE CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #16645 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1816 Gunbarrel Rd, Chattanooga, TN 37421 |
| Phone Number | 423-954-9063 |
News Archive
Genetic testing for a certain mutation in pediatric patients is valuable in determining a cause for unexplained hearing loss, according to a study in the November 2012 issue of Otolaryngology-Head and Neck Surgery.
Cardiac patients who also have diabetes will be able to do their rehabilitation exercises more safely, thanks to the world's first guidance on the subject, which has been published by international experts including a Swansea University academic.
For snakes, spiders, and other venomous creatures, the "business end," or active part, of a toxin is the area on the surface of a protein that is most likely to undergo rapid evolution in response to environmental constraints, say researchers from Ben Gurion University in Israel.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 3 days ago
News Archive
Genetic testing for a certain mutation in pediatric patients is valuable in determining a cause for unexplained hearing loss, according to a study in the November 2012 issue of Otolaryngology-Head and Neck Surgery.
Cardiac patients who also have diabetes will be able to do their rehabilitation exercises more safely, thanks to the world's first guidance on the subject, which has been published by international experts including a Swansea University academic.
For snakes, spiders, and other venomous creatures, the "business end," or active part, of a toxin is the area on the surface of a protein that is most likely to undergo rapid evolution in response to environmental constraints, say researchers from Ben Gurion University in Israel.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 3 days ago
20/20 Optical Llc Type: Non-Pharmacy Dispensing Site Location: 7268 Jarnigan Rd, Chattanooga, Tennessee 37421 Phone: (423) 899-3930 | |
Access Durable Medical Equipment Ll Type: Pharmacy Location: 4062 Hixson Pike, Chattanooga, Tennessee 37415 Phone: (423) 877-3568 | |
Advanced Respiratory, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5959 Shallowford Rd, Chattanooga, Tennessee 37421 Phone: (423) 825-4054 | |
Amerita, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5959 Shallowford Rd, Chattanooga, Tennessee 37421 Phone: (423) 893-9335 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5959 Shallowford Rd 545, Chattanooga, Tennessee 37421 Phone: (423) 499-0212 |